Life sciences

Empowering life sciences with advisory and tax.

Transform complex challenges in the life sciences sector into innovative and elegant solutions with KPMG’s tailored tax and advisory expertise, securing growth, compliance and competitiveness.

Navigating Demark’s life sciences landscape effectively, which is driven by innovation and technological advancements, is crucial. While there are many different life science players such as startups, biotech, pharmaceuticals, medical technology, contract manufacturers and diagnostic firms, there are unique challenges which are applicable to all entities in this sector.

At KPMG, we offer specialized tax and advisory insights and solutions tailored to these key concerns including addressing issues related to compliance and regulation requirements, complex global supply chains, talent and valuable intellectual property.

Our team leverage our local expertise, global insights and our unique 360° approach in order to enable your business to thrive amid the industry's evolving challenges, ensuring compliance, fostering innovation, and driving sustainable growth. Partner with us to navigate the complexities and capitalize on the opportunities for your company!

What we do

Address your industry's key challenges within tax and advisory with our strategic solutions.

A Middle Eastern male and Caucasian female, clad in white lab coats, concentrate on analyzing specimen under a microscope, amidst scientific tools in a bright laboratory setting.

R&D (Research and Development), often comes with high stakes and uncertain outcomes. Protecting and optimizing IP assets is therefore crucial. We guide companies through the intricacies of IP-related taxation, ensuring efficient structuring to avoid exit taxation and manage cross-border royalty and withholding tax complexities.

Further, we have supported life science companies with the tax-related impact of acquisition of intellectual property and of other life science companies. Our Pillar 2 and international tax experts have advised Life Science clients on the impact of this regulation on their activities.

Our credits, grants and incentives service is designed to maximize investment while mitigating risks of non-commercial projects and transfer pricing scrutiny in international trials.

Successfully bringing products to market in Denmark and also internationally, requires careful navigation of the tax considerations.

KPMG is able to support with all aspects of tax from VAT implications, utilizing loss carryforwards, to aligning transfer pricing models with local market risks as well as remuneration models for sales channels (entrepreneurs, distributors, agents etc.)

Attracting talent is vital for innovation, especially in an internationally competitive market. We provide guidance on Denmark's tax regimes and structured equity schemes, supporting your business with our global mobility solutions.

Maintaining compliance and ethical integrity is crucial for preserving reputational capital. Our team will steer your business to be compliant with your business tax compliance obligations globally, including BEPS requirements.

We can also support in proactive dialogue with tax authorities in the context of advance pricing agreements (APA), tax audits and disputes.

Life science companies are vulnerable to changes in foreign tax rules and tariffs as well as other geopolitical and economic factors.

KPMG is able to advise and provide insight in how to adapt to these changes successfully, offering services such as comprehensive cross-border tax planning for regulatory changes, international ESG considerations, transformation of your functions to meet global challenges.